相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
Shigeyuki Chaki
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
B. Kadriu et al.
MOLECULAR PSYCHIATRY (2018)
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou et al.
MOLECULAR PSYCHIATRY (2018)
Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
Jerome H. Taylor et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study
John Hartberg et al.
PSYCHOPHARMACOLOGY (2018)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
What Are the Causes for Discrepancies of Antidepressant Actions of (2R, 6R)-Hydroxynorketamine?
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2018)
Rapid antidepressant effect of S-ketamine in schizophrenia
Lucie Bartova et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Shabah Mohammad Shadli et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
Lijia Chang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
Paul Glue et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Jun-ichi Yamaguchi et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine
Zheng Tian et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
Randall L. Morrison et al.
PSYCHOPHARMACOLOGY (2018)
Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model
Kai Zhang et al.
SCIENTIFIC REPORTS (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
Chen Mu-Hong et al.
PSYCHIATRY RESEARCH (2018)
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
Ruin Moaddel et al.
PSYCHOPHARMACOLOGY (2018)
Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
Kai Zhang et al.
PSYCHOPHARMACOLOGY (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Kenichi Fukumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
Minkyung Park et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
Aurora J. A. E. van de Loo et al.
PSYCHOPHARMACOLOGY (2017)
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
D. D. Kiraly et al.
TRANSLATIONAL PSYCHIATRY (2017)
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2017)
(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2017)
Classics in Chemical Neuroscience: Ketamine
Marshall W. Tyler et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
Fernanda S. Correia-Melo et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight
Ilina Singh et al.
LANCET PSYCHIATRY (2017)
Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis
Katerina Papadimitropoulou et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
C. K. Loo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
Kenji Hashimoto
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
Rebecca A. Brachman et al.
BIOLOGICAL PSYCHIATRY (2016)
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Jaskaran B. Singh et al.
BIOLOGICAL PSYCHIATRY (2016)
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Marko A. Peltoniemi et al.
CLINICAL PHARMACOKINETICS (2016)
Ketamine's antidepressant action: beyond NMDA receptor inhibition
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Ketamine: 50 Years of Modulating the Mind
Linda Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
Chun Yang et al.
PSYCHIATRY RESEARCH (2016)
R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
K. Hashimoto
PSYCHOLOGICAL MEDICINE (2016)
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
T. Kishimoto et al.
PSYCHOLOGICAL MEDICINE (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Serum Interleukin-6 Is a Predictive Biomarker for Ketamine's Antidepressant Effect in Treatment-Resistant Patients With Major Depression
Jian-Jun Yang et al.
BIOLOGICAL PSYCHIATRY (2015)
Concomitant Benzodiazepine Use Attenuates Ketamine Response
Mark A. Frye et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
Bruno Romeo et al.
PSYCHIATRY RESEARCH (2015)
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
J. W. Murrough et al.
PSYCHOLOGICAL MEDICINE (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer
Alexander Viktorin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Neural correlates of rapid antidepressant response to ketamine in bipolar disorder
Allison C. Nugent et al.
BIPOLAR DISORDERS (2014)
R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji-chun Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial
Adriana Feder et al.
JAMA PSYCHIATRY (2014)
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Kenji Hashimoto
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression
Mark J. Niciu et al.
BIOLOGICAL PSYCHIATRY (2013)
Acute Increases in Plasma Mammalian Target of Rapamycin, Glycogen Synthase Kinase-3β, and Eukaryotic Elongation Factor 2 Phosphorylation After Ketamine Treatment in Three Depressed Patients
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
Diogo R. Lara et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Carolyn I. Rodriguez et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
Michael H. Bloch et al.
BIOLOGICAL PSYCHIATRY (2012)
Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
Gonzalo Laje et al.
BIOLOGICAL PSYCHIATRY (2012)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
Kenji Hashimoto
Clinical Psychopharmacology and Neuroscience (2012)
Monitoring Ketamine treatment Response in a Depressed Patient via Peripheral Mammalian target of Rapamycin Activation
Magdalena C. Denk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
Kenji Hashimoto
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
被撤回的出版物: A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department (Retracted article. See vol. 20, pg. 611, 2017)
Gregory Luke Larkin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
The correlation between ketamine and posttraumatic stress disorder in burned service members
Laura L. McGhee et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
